American Century Investments

The Stowers Institute for Medical Research, a Kansas City-based biomedical nonprofit, has held majority ownership since 2000. The Stowers family retains minority voting control, but more than 40% of American Century's profits flow to the Institute to fund genomic and cancer research. No external shareholders or parent company exert commercial pressure on distributions.

The Institute does not direct investment decisions. American Century operates independently under CEO Jonathan Thomas and its investment leadership. The structural benefit is alignment: the firm's profit distributions fund long-term scientific research rather than quarterly dividends to public shareholders, reinforcing a long-duration investment culture across equity and fixed-income teams.

Not in venture capital or traditional buyout private equity. The firm's alternatives exposure runs through hedge fund replication strategies, publicly traded real estate securities, and a growing private credit platform. In September 2023 it launched the American Century Private Credit Fund, an interval fund targeting middle-market direct lending (per SEC filings).

Institutional allocators access American Century through separate accounts, commingled funds, collective investment trusts, and a growing ETF lineup. Core strategies include U.S. large-cap growth and value equity, international and emerging-market equity, multi-sector fixed income, global real estate securities, and alternatives. The firm also subadvises mandates for third-party platforms.

American Century integrates ESG factors in select strategies but does not market a firm-wide impact mandate. Its structural impact is intrinsic: the Stowers Institute ownership means a significant portion of firm revenue funds biomedical research automatically, independent of any fund-level ESG label. The firm does not run dedicated impact or green bond funds at scale.

James Stowers Jr. founded the firm in 1958 and led it for decades. He transferred ownership to the Stowers Institute in 2000. Jonathan Thomas became CEO in 2007 and has since tripled assets under management. The Stowers Institute board retains governance representation, but day-to-day investment and business decisions rest with Thomas and the management committee.

The firm distributes strategies across North America, Europe, and Asia-Pacific. U.S. institutional and retail distribution runs from Kansas City and New York. International distribution teams operate from London, Hong Kong, and Sydney, with particular emphasis on U.S. equity strategies for non-U.S. institutional clients.